Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
aacr
Apr 12, 2024, 11:49 |
Drugs
Vasileios Askoxylakis: Promising clinical data from the Phase 1 study of the CCR7 targeting antibody-drug conjugate JBH492
Vasileios Askoxylakis, Vice President, Global Head Oncology Early Clinical Development at Servier, shared on LinkedIn: "Very…
Apr 12, 2024, 11:02 |
Blog
Nicholas Navin: Systems Biology at the MD Anderson Cancer Center in Houston, Texas is recruiting faculty
Nicholas Navin, Professor and Chair, Department of Systems Biology at MD Anderson Cancer Center, shared on…
Apr 12, 2024, 07:30 |
Blog
Urvi Shah: Grateful that our paper was selected for the inaugural Clinical Cancer Research early career award
Urvi Shah, Hematologist-oncologist at Memorial Sloan Kettering Cancer Center, shared a post on X: "Thank…
Apr 11, 2024, 16:56 |
Blog
Vivek Subbiah: Their leadership as early-phase clinical trialists is truly inspiring
Vivek Subbiah shared on X/Twitter: "What an honor to meet and extend congratulations to AACR…
Apr 11, 2024, 16:41 |
Blog
Udhayvir Grewal: Being a peer mentor is one of my favorite parts of being a fellow
Udhayvir Grewal, Hematology and Oncology Fellow at the University of Iowa Holden Comprehensive Cancer Center, shared…
Apr 11, 2024, 15:23 |
Drugs
Piotr Wysocki: Adagrasib and cetuximab in KRAS G12C-mutated colorectal cancer is a safe and active
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 11, 2024, 13:50 |
Insight
New blood test predicts clinical benefit to IO AND identifies which patient will develop toxicity by Jarushka Naidoo - LUNGevity Foundation
LUNGevity Foundation shared on X/Twitter: "50% patients develop side effects from immunotx. New blood test predicts…
Apr 11, 2024, 12:45 |
Insight
Important IMvoke010 trial could shape future research in immunotherapy in locally advanced head and neck cancer - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on X/Twitter: "Important IMvoke010 trial could shape future research in immunotherapy…
Apr 11, 2024, 12:10 |
Blog
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma, by Sumanta K. Pal et al - Cancer Discovery
Cancer Discovery shared on X/Twitter: "Just published with the AACR24 Clinical Plenary presentation: CD70-Targeted Allogeneic CAR…
Apr 11, 2024, 06:46 |
Opinion
Maria Natalia Gandur Quiroga: The Hallmarks of Precancer
Maria Natalia Gandur Quiroga shared a post on X: "The Hallmarks of Precancer. AACR Journals,…
41
42
43
44
45
All:
585
Posts:
421 - 430
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube